These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7742578)

  • 21. The impact of long-term cyclosporin-A therapy on hematological and biochemical profile in renal transplant patients.
    Islam SI; Ezeamuzie CI; Shaheen FA; Sheikh IA; Masuda QN; Khaleel MH
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):315-21. PubMed ID: 7582381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies.
    Töz H; Sen S; Seziş M; Duman S; Ozkahya M; Ozbek S; Hoşcoşkun C; Atabay G; Ok E
    Transplant Proc; 2004; 36(1):134-6. PubMed ID: 15013324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
    Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
    Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alendronate is effective to treat bone loss in renal transplantation recipients.
    Lan G; Peng L; Xie X; Peng F; Wang Y; Yu S
    Transplant Proc; 2008 Dec; 40(10):3496-8. PubMed ID: 19100422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
    Sahin G; Yasar NS; Sirmagul B; Bal C; Yalcin AU
    Ren Fail; 2008; 30(10):992-9. PubMed ID: 19016151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone.
    Casez JP; Lippuner K; Horber FF; Montandon A; Jaeger P
    Nephrol Dial Transplant; 2002 Jul; 17(7):1318-26. PubMed ID: 12105258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mineral density in the long term after liver transplantation.
    Hamburg SM; Piers DA; van den Berg AP; Slooff MJ; Haagsma EB
    Osteoporos Int; 2000; 11(7):600-6. PubMed ID: 11069194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression.
    Chapman JR; Marcen R; Arias M; Raine AE; Dunnill MS; Morris PJ
    Transplantation; 1987 Jun; 43(6):860-4. PubMed ID: 3296353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
    Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y; van Yperselede de Strihou C
    Clin Nephrol; 2003 Mar; 59(3):190-5. PubMed ID: 12653262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between aseptic necrosis of femoral head bone and immunosuppression therapy, especially CsA administration].
    Sato K; Satomi S; Oguma S; Ohkohchi N; Okazaki H; Taguchi Y; Mori S
    Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):832-9. PubMed ID: 8377759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone loss in long-term renal transplantation: histopathology and densitometry analysis.
    Cueto-Manzano AM; Konel S; Hutchison AJ; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R
    Kidney Int; 1999 May; 55(5):2021-9. PubMed ID: 10231467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral density after renal transplantation in children.
    Feber J; Cochat P; Braillon P; Castelo F; Martin X; Glastre C; Chapuis F; David L; Meunier PJ
    J Pediatr; 1994 Dec; 125(6 Pt 1):870-5. PubMed ID: 7996358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Spontaneous growth of children with chronic renal failure].
    Kohlhauser C; Balzar E; Frisch H
    Klin Padiatr; 1995; 207(5):281-4. PubMed ID: 7500604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olpadronate prevents the bone loss induced by cyclosporine in the rat.
    Zeni SN; Gregorio S; Gomez AC; Somoza J; Mautalen C
    Calcif Tissue Int; 2002 Jan; 70(1):48-53. PubMed ID: 11907707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testicular function after renal transplantation: comparison of Cyclosporin A with azathioprine and prednisone combination regimes.
    Handelsman DJ; McDowell IF; Caterson ID; Tiller DJ; Hall BM; Turtle JR
    Clin Nephrol; 1984 Sep; 22(3):144-8. PubMed ID: 6386252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bone mineral content after successful renal transplantation].
    Imamura A
    Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1642-8. PubMed ID: 2287111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunosuppressive therapy with the use of cyclosporin A in the late period after a kidney transplant].
    Rozenthal' RL; Bitsans IaB; Berzinia RE; Shevelev VN; Il'inskiĭ IM
    Ter Arkh; 1992; 64(6):61-3. PubMed ID: 1440341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.